Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Bullboard Posts
Post by 1hot-techwomanon Mar 08, 2018 12:07pm
111 Views
Post# 27683821

Patience will win out on this one :) See you in the Summer !

Patience will win out on this one :) See you in the Summer !ABcann Global Completes $70 Million Bought Deal Financing and $4.8 Million Exercise of Underwriters' Over-Allotment Option Wednesday, February 28, 2018, 9:28 AM ET ABcann Global Completes $70 Million Bought Deal Financing and $4.8 Million Exercise of Underwriters' Over-Allotment Option THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. NAPANEE, Ontario, Feb. 28, 2018 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSXV:ABCN) ("ABcann" or the "Company") is pleased to announce that it has closed its bought deal financing, as previously announced on January 29, 2018, of: (i) 11,500,000 units (each, a "Unit") of the Company at a price of $3.50 per Unit, for aggregate gross proceeds of $40,250,000 (the "Unit Offering"); and (ii) 30,000 6.0% unsecured convertible debentures (each, a "Convertible Debenture") of the Company at a price of $1,000 per Convertible Debenture, for aggregate gross proceeds of $30,000,000 (the "Debenture Offering" and collectively with the Unit Offering, the "Offering"). The Offering was conducted by a syndicate of underwriters led by Canaccord Genuity Corp. and Eight Capital and including GMP Securities L.P. and PI Financial Corp. (collectively, the "Underwriters"). In addition, the Offering included 862,500 Warrants (defined below) and 4,500 Convertible Debentures sold pursuant to the exercise of the Underwriters' over-allotment option, for additional aggregate gross proceeds of $4,793,250. "Completion of the Offering further increases our cash position to over $135 million and will allow us to pursue multiple opportunities and execute our strategic vision," stated Barry Fishman, ABcann's Chief Executive Officer.
Bullboard Posts